196 related articles for article (PubMed ID: 11972979)
21. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of Twinrix in older adults: a critical analysis.
Stoffel M; Lievens M; Dieussaert I; Martin I; André F
Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
24. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.
Murdoch DL; Goa K; Figgitt DP
Drugs; 2003; 63(23):2625-49. PubMed ID: 14636084
[TBL] [Abstract][Full Text] [Related]
25. Combined two-dose hepatitis A and B vaccine (AmBirix).
Jarvis B; Figgitt DP
Drugs; 2003; 63(2):207-13; discussion 214-5. PubMed ID: 12515566
[TBL] [Abstract][Full Text] [Related]
26. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
Van Der Wielen M; Van Damme P; Collard F
Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
[TBL] [Abstract][Full Text] [Related]
29. [Safety and immunogenicity of combined hepatitis A and hepatitis B vaccine according to 0 and 6 months schedule in healthy children].
Wang YL; Chen WY; Xu WG; Wang X; Liu Y; Wu JF; Chen JT
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Feb; 44(2):154-6. PubMed ID: 20388338
[TBL] [Abstract][Full Text] [Related]
30. The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.
Chen Y; Gu H; Cheng S; Shen L; Cui F; Wang F; Yao J; Xia S; Lv H; Liang X
Hum Vaccin Immunother; 2013 Apr; 9(4):898-902. PubMed ID: 23295964
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents.
Thompson SC; Norris M
Int J Infect Dis; 1998; 2(4):193-6. PubMed ID: 9763500
[TBL] [Abstract][Full Text] [Related]
32. Reactogenicity of a combined hepatitis A and hepatitis B vaccine in healthy Indian children and adults.
Aggarwal R; Balachandran A; Menon U; Nagpal R; Pokharna G; Rao S; Shah D; Srinivasa K; Datta S; Bock H
Indian J Gastroenterol; 2007; 26(5):248-9. PubMed ID: 18227581
[No Abstract] [Full Text] [Related]
33. A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trial.
Østergaard L; Silfverdal SA; Berglund J; Flodmark CE; West C; Bianco V; Baine Y; Miller JM
Vaccine; 2012 Jan; 30(4):774-83. PubMed ID: 22107850
[TBL] [Abstract][Full Text] [Related]
34. Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents.
Diaz-Mitoma F; Law B; Subramanya A; Hoet B
Vaccine; 2008 Mar; 26(14):1759-63. PubMed ID: 18336963
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users.
Lugoboni F; Quaglio G; Pajusco B; Civitelli P; Romanò L; Bossi C; Spilimbergo I; Mezzelani P
Addiction; 2004 Dec; 99(12):1560-4. PubMed ID: 15585047
[TBL] [Abstract][Full Text] [Related]
36. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
37. The first combined vaccine against hepatitis A and B: an overview.
Thoelen S; Van Damme P; Leentvaar-Kuypers A; Leroux-Roels G; Bruguera M; Frei PC; Bakasenas V; Safary A
Vaccine; 1999 Mar; 17(13-14):1657-62. PubMed ID: 10194819
[TBL] [Abstract][Full Text] [Related]
38. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C
J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380
[TBL] [Abstract][Full Text] [Related]
39. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
40. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
Cardell K; Akerlind B; Sällberg M; Frydén A
J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
